StockData
ALVONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as ALVOW

Alvotech

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 31, 2026
$5.03+0.03 (+0.60%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
50.3
Dividend yield
–

Alvotech revenue by segment

No segment breakdown reported

Alvotech does not break out revenue by segment, region or product in the tagged data of its filings for this period type.